MARKET

MCK

MCK

McKesson
NYSE

Real-time Quotes | Nasdaq Last Sale

201.89
-5.86
-2.82%
After Hours: 198.27 -3.62 -1.79% 17:16 09/20 EDT
OPEN
205.87
PREV CLOSE
207.75
HIGH
205.87
LOW
199.78
VOLUME
933.08K
TURNOVER
--
52 WEEK HIGH
210.00
52 WEEK LOW
141.32
MARKET CAP
31.23B
P/E (TTM)
-7.1573
1D
5D
1M
3M
1Y
5Y
Insider Sell: Mckesson
MT Newswires · 5d ago
Mckesson Corp (MCK) EVP & CFO Britt J. Vitalone Sold $4.5 million of Shares
GuruFocus News · 5d ago
Endo Shares Move Higher On Settlement Of New York State Opioid Cases
Benzinga · 09/10 11:31
Disciplined Core Value Fund Buys HCA Healthcare Inc, Blackstone Inc, Owens-Corning Inc, Sells ...
GuruFocus News · 09/09 19:38
BRIEF-McKesson Says Board Size Increased From Nine To 10 Members
reuters.com · 09/07 14:08
Mckesson's Board of Directors Elects Dr. Richard H. Carmona as New Independent Director
McKesson Corporation (NYSE:MCK) announced today that the McKesson board of directors has elected Dr. Richard H. Carmona as an independent director and member of the board's Compensation and Compliance Committees, effective Sept. 6, 2021.
Business Wire · 09/07 12:23
UPDATE 2-Drug companies say enough U.S. states join $26 bln opioid settlement to proceed
reuters.com · 09/04 23:25
Opioid Distributors to Move Forward With $26 Billion Accord
Bloomberg · 09/04 23:10
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MCK. Analyze the recent business situations of McKesson through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MCK stock price target is 240.38 with a high estimate of 270.00 and a low estimate of 210.00.
EPS
Institutional Holdings
Institutions: 1.33K
Institutional Holdings: 153.45M
% Owned: 99.21%
Shares Outstanding: 154.67M
TypeInstitutionsShares
Increased
328
6.59M
New
84
2.16M
Decreased
356
9.44M
Sold Out
74
481.02K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Drug Retailers
-2.55%
Food & Drug Retailing
-1.39%
Key Executives
Non-Executive Chairman/Independent Director
Edward Mueller
Chief Executive Officer/Director
Brian Tyler
Chief Financial Officer/Executive Vice President
Britt Vitalone
Chief Human Resource Officer/Executive Vice President
Tracy Faber
Executive Vice President/Chief Technology Officer/Chief Information Officer
Nancy Flores
Executive Vice President/General Counsel
Lori Schechter
Executive Vice President
Tom Rodgers
Senior Vice President/Chief Accounting Officer/Controller
Kevin Emerson
Independent Director
Richard Carmona
Independent Director
Dominic Caruso
Independent Director
Donald Knauss
Independent Director
Brad Lerman
Independent Director
Linda Mantia
Independent Director
Maria Martinez
Independent Director
Susan Salka
Independent Director
Kenneth Washington
Declaration Date
Dividend Per Share
Ex-Div Date
07/26/2021
Dividend USD 0.47
08/31/2021
04/29/2021
Dividend USD 0.42
05/31/2021
01/28/2021
Dividend USD 0.42
03/01/2021
10/29/2020
Dividend USD 0.42
11/30/2020
07/29/2020
Dividend USD 0.42
08/31/2020
04/29/2020
Dividend USD 0.41
05/29/2020
01/29/2020
Dividend USD 0.41
02/28/2020
10/23/2019
Dividend USD 0.41
11/29/2019
07/31/2019
Dividend USD 0.41
08/30/2019
04/24/2019
Dividend USD 0.39
05/31/2019
01/31/2019
Dividend USD 0.39
02/28/2019
10/24/2018
Dividend USD 0.39
11/30/2018
07/25/2018
Dividend USD 0.39
08/31/2018
04/25/2018
Dividend USD 0.34
05/31/2018
02/01/2018
Dividend USD 0.34
02/28/2018
10/25/2017
Dividend USD 0.34
11/30/2017
07/28/2017
Dividend USD 0.34
08/30/2017
05/25/2017
Dividend USD 0.28
06/01/2017
01/25/2017
Dividend USD 0.28
02/27/2017
10/28/2016
Dividend USD 0.28
11/29/2016
About MCK
McKesson Corporation is focused distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The Company’s segments include U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. The International segment provides distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. RxTS segment combines its technologies, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, to serve its biopharma and life sciences partners and patients.

Webull offers kinds of McKesson Corporation stock information, including NYSE:MCK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MCK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MCK stock methods without spending real money on the virtual paper trading platform.